SAN FRANCISCO, Feb. 08, 2017 -- Sunrun (Nasdaq:RUN) today announced that it will issue its fourth quarter and fiscal year 2016 earnings report after the market closes Wednesday, March 8, 2017.
A conference call has been scheduled to discuss these earnings results at 2:00 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at http://investors.sunrun.com or over the phone by dialing (877) 470-1078 (domestic) or (615) 247-0087 (international) using ID #65847799. A replay will be available following the call via the Sunrun Investor Relations website or for one week at the following numbers (855) 859-2056 (domestic) or (404) 537-3406 (international) using ID #65847799.
About Sunrun
Sunrun (Nasdaq:RUN) is the largest dedicated residential solar company in the United States with a mission to create a planet run by the sun. Since establishing the solar as a service model in 2007, Sunrun continues to lead the industry in providing clean energy to homeowners with little to no upfront cost and at a savings to traditional electricity. The company designs, installs, finances, insures, monitors and maintains the solar panels on a homeowner's roof, while families receive predictable pricing for 20 years or more. For more information please visit: www.sunrun.com.
Investor Relations Contact [email protected] Patrick Jobin Vice President, Finance & Investor Relations 415-638-4007 Charlotte Coultrap-Bagg Director, Finance & Investor Relations 415-510-4833


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Italy Fines Apple €98.6 Million Over App Store Dominance
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 



